CytomX Therapeutics, Inc. Accumulated Other Comprehensive Income
CytomX Therapeutics, Inc. (CTMX) had Accumulated Other Comprehensive Income of -$196.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$196.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $102.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $111.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $104.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$196.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $102.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $111.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $104.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $33.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | -$1.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $27.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $40.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$4.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$10.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $95.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | -$63.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $35.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $26.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $10.00K 10-K · filed 2024-03-11 |
| 2022-09-30 | -$795.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$1.16M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$919.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$242.00K 10-K/A · filed 2023-03-27 |
| 2021-09-30 | $52.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $15.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$43.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$47.00K 10-K/A · filed 2023-03-27 |
| 2020-09-30 | -$47.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $16.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $336.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $57.00K 10-K · filed 2021-02-24 |
| 2019-09-30 | $110.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $209.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $73.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$93.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | -$208.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | -$178.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$228.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$94.00K 10-K · filed 2019-02-27 |
| 2017-09-30 | -$61.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$110.00K 10-Q · filed 2017-08-07 |
| 2017-03-31 | -$100.00K 10-Q · filed 2017-05-05 |
| 2016-12-31 | -$27.00K 10-K · filed 2018-03-07 |
| 2016-09-30 | $6.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $80.00K 10-Q · filed 2016-08-03 |
| 2016-03-31 | $30.00K 10-Q · filed 2016-05-06 |
| 2015-12-31 | -$76.00K 10-K · filed 2017-03-02 |
| 2015-09-30 | $8.00K 10-Q · filed 2015-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |